Eagle Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Eagle Pharmaceuticals

09/05/2022 14:31

* Eagle Pharmaceuticals Inc  EGRX.OQ  reported quarterly
adjusted
earnings of $4.04​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of $3.88 per share.
    * Revenue rose 180.9% to $115.87 million from a year ago; 
analysts expected $123.33 million. 
    * Eagle Pharmaceuticals Inc's reported EPS for the quarter
was
$3.41​.
    * The mean earnings estimate of analysts had risen by
about 246.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Eagle Pharmaceuticals Inc shares had fallen by 12.6% this
quarter and lost 15.1% so far this year.
    * The company reported quarterly net income of $44.06
million.
    * Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $49.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 01:30 p.m.  ​All
figures in US dollars unless otherwise stated